AGI Grosses EUR 42.5M In Dublin, London IPO

DUBLIN, Ireland - AGI Therapeutics plc, a specialty pharma company established by former Elan Corp. plc executives, raised gross proceeds of 42.5 million ($50.3 million) in an initial public offering Monday on the Irish Stock Exchange in Dublin and the Alternative Investment Market in London. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)